Figure 5.
Figure 5. Time courses of clinical cases. (A) Serum levels of both hepcidin-25 and ferritin increased with intravenous iron administration for 8 weeks in a patient with iron deficiency anemia receiving hemodialysis. (B) Serum levels of both hepcidin-25 and ferritin gradually decreased in the period of 4 months in a patient receiving hemodialysis who had massive periodic hemorrhage as a result of menstruation. (C-D) The expression of hepcidin in inflammation. Protein profiling of urine (C) and serum (D) from a patient with acute pyelonephritis before (day 0) and after (day 17) treatment with antibiotics is shown. AU indicates arbitrary unit.

Time courses of clinical cases. (A) Serum levels of both hepcidin-25 and ferritin increased with intravenous iron administration for 8 weeks in a patient with iron deficiency anemia receiving hemodialysis. (B) Serum levels of both hepcidin-25 and ferritin gradually decreased in the period of 4 months in a patient receiving hemodialysis who had massive periodic hemorrhage as a result of menstruation. (C-D) The expression of hepcidin in inflammation. Protein profiling of urine (C) and serum (D) from a patient with acute pyelonephritis before (day 0) and after (day 17) treatment with antibiotics is shown. AU indicates arbitrary unit.

Close Modal

or Create an Account

Close Modal
Close Modal